Close Menu

NEW YORK – Scottish startup BioCaptiva, a University of Edinburgh spinout, has raised £1 million ($1.4 million) in a seed financing round.

The firm will use the funding to license the technology for its BioCollector liquid biopsy platform from the university and launch initial trials. 

The financing round was led by Edinburgh-based business angel investment syndicate Archangels, as well as Scottish Enterprise.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

May
26
Sponsored by
Lexogen

The emergence of cell clones that are resistant to targeted therapies poses a significant issue in the treatment of metastatic melanoma.

Jun
08
Sponsored by
Qiagen

Cancer is a complex and heterogeneous disease requiring patient-specific molecular analysis to support treatment decisions.

Jun
18
Sponsored by
Canexia Health

Last year, by Precision Oncology News' count, the FDA approved 27 precision oncology drugs, a 35 percent increase in the number of approvals from 2019.